Editorial
Published in:
Vnitř Lék 2022; 68(2): 79
Category:
Editorial
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2022 Issue 2
Most read in this issue
- Oral semaglutide – Rybelsus®, the first GLP-1 receptor agonist for oral use in clinical practice
- The position of SGLT2 inhibitors in current medical practice – update 2022
- Anticoagulation in cancer patients; new recommendations based on randomized clinical trials
- Prediabetes